GAA: Ƙara Basirar Ƙwaƙwalwa? Sakamakon Gwaji na Makonni 6 Ya Bayyana
GAA, sinadarin da ake talla a matsayin ƙara basira, ya samu gwajin farko a kan mutane. A cikin gwaji mai ɗaukar makonni 6 da ya kunshi matasa 58 masu lafiya, an ga ɗan hanzari a wasu gwaje‑gwajen saurin amsawa da alamun sauƙaƙe damuwa. Sai dai mafi yawan gwaje‑gwajen tunani ba su nuna tasiri ba, kuma sakamakon da ake taɓawa a kan manyan taken yawanci alamu ne kawai. Kodayake aminci ya yi ƙwazo, gwajin kaɗan ne, ba a kwatanta GAA da creatine kai‑kawai ba, kuma ƙungiyar tallafa wa ba ta da muradin tallata creatine. Ga abin da aka gano a zahiri, wanene zai iya amfana da shi, da dalilin da yasa hukuncin ke da ruɗani.
GAA Ya Fi Creatine a Ƙarfin Hannu Ga Masu Sama da Shekaru 65
Wani ƙaramar gwaji da aka gudanar a tsakanin manya masu shekaru 65 da sama ya nuna cewa guanidinoacetic acid (GAA), tsari na kai tsaye na creatine, ya ƙara ƙarfin hannun sosai fiye da creatine monohydrate. Sai dai gwajin ya ɗauki makonni takwas ne kawai, wanda ya ƙunshi mutanen 21 da suka kammala, ba tare da an haɗa shirin motsa jiki ba, kuma ƙididdigar amincewa da sakamakon na kusan sifili. GAA ya kuma rage myostatin da ƙara wasu alamu a BIA masu alaka da tsoka, duk da cewa wasu daga ciki na iya kasancewa sakamakon ruwan jiki. Dole ne a kula da homocysteine, domin GAA na ƙara wannan sinadari ta hanyar cinye ƙungiyoyin methyl. Wannan shine abin da binciken ya gano, abin da ba za a iya faɗi ba, da dalilin da ya sa creatine monohydrate har yanzu ke zama zaɓi mafi aminci.